UBA5

Mutation & survival
SurvivalMutationKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, UBA5 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated UBA5 data layer compared with 25 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher UBA5 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated UBA5 expression acts as an unfavorable survival marker.

COAD and UCEC are the cancer types where UBA5 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
COADOSMedianIII,IV0.0560.781<.00118view →
UCECOSMedianIV0.2310.592.0366view →
Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

UBA5–COAD (OS)

Kaplan–Meier survival curve for UBA5 mutant vs wild-type samples in COAD.

Open the COAD breakdown →

Exploration